Screener
D&A at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Surgery Partners, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: Surgery Partners, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001638833-26-000046
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Other operating expenses | 58.8 | 43.6 |
| Cost of revenues | 650.7 | 614.1 |
| General and administrative expenses | 39.3 | 36.0 |
| Depreciation and amortization | 38.5 | 36.3 |
| Transaction and integration costs | 15.6 | 24.7 |
| Net loss on disposals, consolidations and deconsolidations | 4.3 | 6.4 |
| Equity in earnings of unconsolidated affiliates | (4.1) | (5.6) |
| Litigation settlements | 2.5 | 2.2 |
Item 1. Financial Statements
FAQ
- What is Surgery Partners, Inc.'s D&A?
- Surgery Partners, Inc. (SGRY) reported D&A of $38.5M in Q1 2026.
- How has Surgery Partners, Inc.'s D&A changed year-over-year?
- Surgery Partners, Inc.'s D&A increased by 6.1% year-over-year, from $36.3M to $38.5M.
- What is the long-term trend for Surgery Partners, Inc.'s D&A?
- Over 4 years (2021 to 2025), Surgery Partners, Inc.'s D&A has grown at a 15.5% compound annual growth rate (CAGR), from $98.8M to $176M.
- What does D&A mean?
- Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.
Ask your AI about Surgery Partners, Inc.'s d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude